Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial

Abstract Background This study aimed to measure the effect of diabetes education using the novel method of “diabetes conversation map (DCM)” as compared to routine counselling (RC) on diabetes management self-efficacy (DMSE) among patients living with type 2 diabetes in Karachi, Pakistan. Methods A...

Full description

Bibliographic Details
Main Authors: Rubina Qasim, Sarfaraz Masih, Mohammad Tahir Yousafzai, Hakim shah, Abdul Manan, Yousaf Shah, Muhammad Yaqoob, Abida Razzaq, Ajmal Khan, Atiya Rahman Khan Rohilla
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Endocrine Disorders
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12902-020-00572-x
id doaj-a2a170ccee2b459293aade263ed42390
record_format Article
spelling doaj-a2a170ccee2b459293aade263ed423902020-11-25T03:50:57ZengBMCBMC Endocrine Disorders1472-68232020-06-0120111010.1186/s12902-020-00572-xDiabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trialRubina Qasim0Sarfaraz Masih1Mohammad Tahir Yousafzai2Hakim shah3Abdul Manan4Yousaf Shah5Muhammad Yaqoob6Abida Razzaq7Ajmal Khan8Atiya Rahman Khan Rohilla9Dow University of Health SciencesDow University of Health SciencesDepartment of Pediatrics and Child Health, Aga Khan UniversityIndus college of Allied Health, The Indus HospitalPatel Hospital and Institute of NursingDow University of Health SciencesDow University of Health SciencesLiaquat National Hospital College of NursingDow University of Health SciencesIndus college of Allied Health, The Indus HospitalAbstract Background This study aimed to measure the effect of diabetes education using the novel method of “diabetes conversation map (DCM)” as compared to routine counselling (RC) on diabetes management self-efficacy (DMSE) among patients living with type 2 diabetes in Karachi, Pakistan. Methods A parallel arm randomized controlled trial among patients with type 2 diabetes aged 30–60 years, with HbA1c > 7%, diagnosed for at least 5 yrs., was conducted at the national institute of diabetes and endocrinology in Karachi, Pakistan. A total 123 type 2 diabetes patients were randomized into DCM (n = 62) or RC (n = 61). Four weekly diabetes control sessions of 40 min each using the DCM or RC was provided. DMSE was measured using a validated Urdu language DMSE tool at baseline and after three months of the randomization. Change in DMSE and HbA1c levels within groups (pre-post) and between the groups after 3 months of enrollment was compared. Results Baseline characteristics except HbA1c were similar between the two arms. After 3 months of enrollment, there was no change in the DMSE score in the RC arm however, significant increase in DMSE score was noted in the DCM arm (P = < 0.001). The average difference (95% confidence interval) in DMSE score between the DCM and RC arm was 33.7(27.3, 40.0; p = < 0.001) after 3 months of the enrollment. Difference in HbA1c within groups was not significant. Conclusions DCM significantly improved DMSE among type 2 diabetes patients in a developing country setting like Pakistan. Healthcare workers caring for type 2 diabetes patients need to be trained on DCM to effectively utilize this novel tool for educating diabetes patients. Trial registration This trial was prospectively registered. ClinicalTrials.gov Identifier: NCT03747471 . Date of registration: Nov 20. 2018.http://link.springer.com/article/10.1186/s12902-020-00572-xDiabetes managementDMSEDiabetes mellitus type 2Conversation mapDiabetes educationDiabetes management self-efficacy
collection DOAJ
language English
format Article
sources DOAJ
author Rubina Qasim
Sarfaraz Masih
Mohammad Tahir Yousafzai
Hakim shah
Abdul Manan
Yousaf Shah
Muhammad Yaqoob
Abida Razzaq
Ajmal Khan
Atiya Rahman Khan Rohilla
spellingShingle Rubina Qasim
Sarfaraz Masih
Mohammad Tahir Yousafzai
Hakim shah
Abdul Manan
Yousaf Shah
Muhammad Yaqoob
Abida Razzaq
Ajmal Khan
Atiya Rahman Khan Rohilla
Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial
BMC Endocrine Disorders
Diabetes management
DMSE
Diabetes mellitus type 2
Conversation map
Diabetes education
Diabetes management self-efficacy
author_facet Rubina Qasim
Sarfaraz Masih
Mohammad Tahir Yousafzai
Hakim shah
Abdul Manan
Yousaf Shah
Muhammad Yaqoob
Abida Razzaq
Ajmal Khan
Atiya Rahman Khan Rohilla
author_sort Rubina Qasim
title Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial
title_short Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial
title_full Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial
title_fullStr Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial
title_full_unstemmed Diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in Pakistan: a randomized controlled trial
title_sort diabetes conversation map - a novel tool for diabetes management self-efficacy among type 2 diabetes patients in pakistan: a randomized controlled trial
publisher BMC
series BMC Endocrine Disorders
issn 1472-6823
publishDate 2020-06-01
description Abstract Background This study aimed to measure the effect of diabetes education using the novel method of “diabetes conversation map (DCM)” as compared to routine counselling (RC) on diabetes management self-efficacy (DMSE) among patients living with type 2 diabetes in Karachi, Pakistan. Methods A parallel arm randomized controlled trial among patients with type 2 diabetes aged 30–60 years, with HbA1c > 7%, diagnosed for at least 5 yrs., was conducted at the national institute of diabetes and endocrinology in Karachi, Pakistan. A total 123 type 2 diabetes patients were randomized into DCM (n = 62) or RC (n = 61). Four weekly diabetes control sessions of 40 min each using the DCM or RC was provided. DMSE was measured using a validated Urdu language DMSE tool at baseline and after three months of the randomization. Change in DMSE and HbA1c levels within groups (pre-post) and between the groups after 3 months of enrollment was compared. Results Baseline characteristics except HbA1c were similar between the two arms. After 3 months of enrollment, there was no change in the DMSE score in the RC arm however, significant increase in DMSE score was noted in the DCM arm (P = < 0.001). The average difference (95% confidence interval) in DMSE score between the DCM and RC arm was 33.7(27.3, 40.0; p = < 0.001) after 3 months of the enrollment. Difference in HbA1c within groups was not significant. Conclusions DCM significantly improved DMSE among type 2 diabetes patients in a developing country setting like Pakistan. Healthcare workers caring for type 2 diabetes patients need to be trained on DCM to effectively utilize this novel tool for educating diabetes patients. Trial registration This trial was prospectively registered. ClinicalTrials.gov Identifier: NCT03747471 . Date of registration: Nov 20. 2018.
topic Diabetes management
DMSE
Diabetes mellitus type 2
Conversation map
Diabetes education
Diabetes management self-efficacy
url http://link.springer.com/article/10.1186/s12902-020-00572-x
work_keys_str_mv AT rubinaqasim diabetesconversationmapanoveltoolfordiabetesmanagementselfefficacyamongtype2diabetespatientsinpakistanarandomizedcontrolledtrial
AT sarfarazmasih diabetesconversationmapanoveltoolfordiabetesmanagementselfefficacyamongtype2diabetespatientsinpakistanarandomizedcontrolledtrial
AT mohammadtahiryousafzai diabetesconversationmapanoveltoolfordiabetesmanagementselfefficacyamongtype2diabetespatientsinpakistanarandomizedcontrolledtrial
AT hakimshah diabetesconversationmapanoveltoolfordiabetesmanagementselfefficacyamongtype2diabetespatientsinpakistanarandomizedcontrolledtrial
AT abdulmanan diabetesconversationmapanoveltoolfordiabetesmanagementselfefficacyamongtype2diabetespatientsinpakistanarandomizedcontrolledtrial
AT yousafshah diabetesconversationmapanoveltoolfordiabetesmanagementselfefficacyamongtype2diabetespatientsinpakistanarandomizedcontrolledtrial
AT muhammadyaqoob diabetesconversationmapanoveltoolfordiabetesmanagementselfefficacyamongtype2diabetespatientsinpakistanarandomizedcontrolledtrial
AT abidarazzaq diabetesconversationmapanoveltoolfordiabetesmanagementselfefficacyamongtype2diabetespatientsinpakistanarandomizedcontrolledtrial
AT ajmalkhan diabetesconversationmapanoveltoolfordiabetesmanagementselfefficacyamongtype2diabetespatientsinpakistanarandomizedcontrolledtrial
AT atiyarahmankhanrohilla diabetesconversationmapanoveltoolfordiabetesmanagementselfefficacyamongtype2diabetespatientsinpakistanarandomizedcontrolledtrial
_version_ 1724489677752238080